Clinical Trial Update: Intranasal Insulin for Posttraumatic Stress Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intranasal insulin for posttraumatic stress disorder is currently recruiting, sponsored by VA Connecticut Healthcare System.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: VA Connecticut Healthcare System | Conditions: PTSD | Phase 2 | Status: RECRUITING